Global Scientific Solutions with Precision and Purpose
Recent Updates
New Nitrosamine Compounds Now Available
Now Operating in San Diego, USA
Stable Isotopes Product Detail
Home Stable Isotopes CS-T-96438

(1S,2R)-Bortezomib-d5

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-96438 Stable Isotopes Research Use Only
(1S,2R)-Bortezomib-d5
Category
Stable Isotopes
API Family
-
Product Code
CS-T-96438
Research Status
For Laboratory Use

(1S,2R)-Bortezomib-d5

0 Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-96438
CAS No.
-
Molecular Formula
C19H20D5BN4O4
Molecular Weight
389.27
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-96438
M.F.
C19H20D5BN4O4
M.W.
389.27
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"(1S,2R)-Bortezomib-d5"
References
"Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)"
Synonyms
B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid-d5
Application Notes
"Isotope labelled (1S,3R)-Bortezomib is an diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway"
Hazard Compound
Refer MSDS for complete information.
Overview
"Isotope labelled (1S,3R)-Bortezomib is an diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway"

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.